Generic Name : Empagliflozin + Linagliptin Indications Linagliptin is indicated in the treatment of type 2 diabetes mellitus to improve glycaemic control in adults. As monotherapy: In patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to intolerance, or contraindicated due to renal impairment. As combination … Read more Pharmacology […]